Executive Order 14297: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients
| Signed | May 12, 2025 |
|---|---|
| Published in the Federal Register | May 15, 2025 |
| Citation | 90 FR 20749 (FR Doc. 2025-08876) |
| Official text | Federal Register ↗ · PDF ↗ |
How the order opens
Section 1 of the order, in its own words (not our summary):
“The United States has less than five percent of the world's population and yet funds around three quarters of global pharmaceutical profits.”
Federal Register notes
The Federal Register's own disposition notes for this order: earlier orders it revokes or amends, and related documents.
← EO 14296: Keeping Promises to Veterans and Establishing a National Center for Warrior Independence EO 14298: Modifying Reciprocal Tariff Rates To Reflect Discussions With the People's Republic of China →
Source: Federal Register API (federalregister.gov). Updated Oct 14, 2026. All executive orders.